Repare Therapeutics Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Repare Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2021 to 2024.
  • Repare Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$28.7M, a 2.29% decline year-over-year.
  • Repare Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$84.7M, a 9.71% increase year-over-year.
  • Repare Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$84.7M, a 9.71% increase from 2023.
  • Repare Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$93.8M, a 223% decline from 2022.
  • Repare Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$29M, a 72.8% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$84.7M +$9.11M +9.71% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 -$93.8M -$64.7M -223% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 -$29M +$77.9M +72.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$107M Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.